- Report
- August 2024
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- August 2024
United States
From €5229EUR$5,500USD£4,393GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Point-of-Care (POC) Coagulation Test market is a subset of the larger Point-of-Care Diagnostics market. It is focused on the development and sale of devices and tests that measure the clotting ability of a patient's blood. These tests are used to diagnose and monitor a variety of conditions, including deep vein thrombosis, pulmonary embolism, and stroke. POC Coagulation Tests are typically small, portable, and easy to use, allowing for quick results in a variety of settings. They are also cost-effective, making them attractive to healthcare providers.
Notable companies in the POC Coagulation Test market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Sysmex Corporation. Show Less Read more